Achieve Life Sciences is trading at $7.68, down 5.07%; no company-specific announcement explained the October 1 decline.

  • Latest identified news was an earlier announcement of a planned CHEST 2026 presentation of 52-week cytisinicline data.
  • Broader indexes also fell modestly; available evidence does not establish a market-driven cause for the sharper move.
  • The 10-year Treasury yield rose to 5.3338%, its highest since April 2002, adding a macroeconomic headwind; its direct role is unclear.